Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

34.16 -2.58 (-7.01%)
Streaming Delayed Price Updated: 2:50 PM EDT, Mar 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,780,376
Open 36.44
Bid (Size) 34.16 (200)
Ask (Size) 34.18 (100)
Prev. Close 36.74
Today's Range 32.88 - 36.65
52wk Range 32.63 - 90.32
Shares Outstanding 8,168,788
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Deadline Approaching: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire

Performance

YTD
-27.6%
-27.6%
1 Month
-15.6%
-15.6%
3 Month
-31.0%
-31.0%
6 Month
-39.8%
-39.8%
1 Year
-26.8%
-26.8%

More News

Read More
News headline image
SLNO CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Lead Plaintiff Deadline on May 5, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
SLNO CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Lead Plaintiff Deadline on May 5, 2026
Via TheNewswire.com
Topics Lawsuit
News headline image
SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Soleno Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action filed by Robbins Geller Rudman & Dowd LLP
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
SOLENO THERAPEUTICS DEADLINE: Investors of Soleno Therapeutics, Inc. (SLNO) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 5, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
SOLENO THERAPEUTICS DEADLINE: Investors of Soleno Therapeutics, Inc. (SLNO) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 5, 2026
Via TheNewswire.com
Topics Lawsuit
News headline image
SOLENO THERAPEUTICS, INC. (SLNO) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Soleno Therapeutics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Law Offices of Howard G. Smith Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Law Offices of Frank R. Cruz Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Deadline to Lead in Securities Fraud Lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) is May 5, 2026 - Contact Kaplan Fox
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Deadline to Lead in Securities Fraud Lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) is May 5, 2026 - Contact Kaplan Fox
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
ROSEN, LEADING INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
SOLENO THERAPEUTICS, INC. (SLNO) INVESTOR ALERT Investors With Large Losses in Soleno Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Kaplan Fox Alerts Investors to a Securities Class Action Against Soleno Therapeutics, Inc. (SLNO) - Deadline is May 5, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Kaplan Fox Alerts Investors to a Securities Class Action Against Soleno Therapeutics, Inc. (SLNO) - Deadline is May 5, 2026
Via TheNewswire.com
Topics Lawsuit
News headline image
Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SLNO
From DJS Law Group
Via Business Wire
News headline image
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire

Frequently Asked Questions

Is Soleno Therapeutics, Inc. - Common Stock publicly traded?
Yes, Soleno Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Soleno Therapeutics, Inc. - Common Stock trade on?
Soleno Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Soleno Therapeutics, Inc. - Common Stock?
The ticker symbol for Soleno Therapeutics, Inc. - Common Stock is SLNO on the Nasdaq Stock Market
What is the current price of Soleno Therapeutics, Inc. - Common Stock?
The current price of Soleno Therapeutics, Inc. - Common Stock is 34.16
When was Soleno Therapeutics, Inc. - Common Stock last traded?
The last trade of Soleno Therapeutics, Inc. - Common Stock was at 03/13/26 02:50 PM ET
What is the market capitalization of Soleno Therapeutics, Inc. - Common Stock?
The market capitalization of Soleno Therapeutics, Inc. - Common Stock is 279.09M
How many shares of Soleno Therapeutics, Inc. - Common Stock are outstanding?
Soleno Therapeutics, Inc. - Common Stock has 279M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.